How Long

So how long do we actually sit around and wait for other people as in the Tysabri trial below

• David Lennon
  
  January 14, 2015 at 10:13 AM Reply ↓
  Thanks for the information, Maureen. Since I first read this I’ve been awaiting news of the outcome of the trial which you mention above as being predicted to end in December 2014. I’ve seen nothing in the media. Are you aware of any further developments? my wife has SPMS, and reacted badly to simvastatins, so Tysabri is really our only other option.
  Many thanks, David
• 
  Maureen Newman
  
  January 29, 2015 at 7:38 PM Reply ↓
  Hello David. Checking on the clinical trial, the primary study completion date has been pushed back to October 2015, with the final study completion expected in March 2017. I was not been able to find any publications indicating preliminary results, but I will keep an eye out. If you want to track the study as well, this is the url to the clinical trial: https://clinicaltrials.gov/ct2/show/NCT01416181
  Best wishes to you and your wife. -Maureen
  
  So if the primary study has been pushed back to October then results from the primary have to correlated probably a minimum of three months just exactly how long are we going to sit on 1102 or is Tysabri a stalling tactic.
  
  In the mean time Innate push on with their trials presently in a PHASE 2b trials
  COSTS
  APPROX $6Mil
  
  
  Experimental SPMS Drug From Innate Immunotherapeutics Shows Success in Early Trials
  
  http://multiplesclerosisnewstoday.c...notherapeutics-shows-success-in-early-trials/
  
  Looks like tysabri are not the only ones going into a lucrative martket by the time we get there it will be overcrowded
  
  Innate also are running a compassionate use programme which looks to be showing some promise.
  
  IF we have no partner for 1102 we have to move on into the Ph2B or sit and get crucified by the market.
  
  WE WAIT FOR TYSABRI
  WE WAIT FOR CORTENDO
  
  FOR WHAT
  
  1102 IS OUR MAIN FOCUS MOVE IT FORWARDS IF NO PARTNER IS FORTHCOMING